Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Tipo

Research/project funding

Posted on

Fecha de Cierre

Reference Number

PAR-22-111

The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.
Categories: Health, Food and Nutrition.

More Information

Visit Website

Tipo

Research/project funding

Posted on

Fecha de Cierre

Reference Number

PAR-22-111

, Estados Unidos